R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure
Medical Science Monitor · 2025
DOI: 10.12659/msm.951530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Emre Hafızoğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey.
- Department of Medical Oncology, Van Training and Research Hospital, Van, Turkey.
ORCID-Profile: Emre Hafızoğlu, Mehmet Salim Demir
Zitieren
APA
Hafızoğlu, E., & Demir, M. S. (2025). R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure. Medical Science Monitor. https://doi.org/10.12659/msm.951530
Vancouver
Hafızoğlu E, Demir MS. R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure. Medical Science Monitor. 2025. doi:10.12659/msm.951530
BibTeX
@article{Hafzolu2025,
author = {Hafızoğlu, Emre and Demir, Mehmet Salim},
title = {R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.951530}
}
EUVIMED